Canlyniadau Chwilio - Tatsuo Hosoya

Mireinio'r Canlyniadau
  1. 1
    Clinical efficacy and safety of topiroxostat in Japanese hyperuricemic patients with or without gout: a randomized, double-blinded, controlled phase 2b study

    Clinical efficacy and safety of topiroxostat in Japanese hyperuricemic patients with or without gout: a randomized, double-blinded, controlled phase 2b study gan Tatsuo Hosoya, Tomomitsu Sasaki, Tetsuo Ohashi

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Safety, efficacy and renal effect of febuxostat in patients with moderate-to-severe kidney dysfunction

    Safety, efficacy and renal effect of febuxostat in patients with moderate-to-severe kidney dysfunction gan Yugo Shibagaki, Iwao Ohno, Tatsuo Hosoya, Kenjiro Kimura

    Cyhoeddwyd 2014
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Function and Localization of Urate Transporter 1 in Mouse Kidney

    Function and Localization of Urate Transporter 1 in Mouse Kidney gan Makoto Hosoyamada, Kimiyoshi Ichida, Atsushi Enomoto, Tatsuo Hosoya, Hitoshi Endou

    Cyhoeddwyd 2004
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Clinical efficacy and safety of topiroxostat in Japanese male hyperuricemic patients with or without gout: an exploratory, phase 2a, multicentre, randomized, double‐blind, placebo‐controlled study

    Clinical efficacy and safety of topiroxostat in Japanese male hyperuricemic patients with or without gout: an exploratory, phase 2a, multicentre, randomized, double‐blind, placebo‐... gan Tatsuo Hosoya, Tetsuhiko Sasaki, Hiroya Hashimoto, Ryusuke Sakamoto, Tetsuo Ohashi

    Cyhoeddwyd 2016
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Comparison of topiroxostat and allopurinol in Japanese hyperuricemic patients with or without gout: a phase 3, multicentre, randomized, double‐blind, double‐dummy, active‐controlled, parallel‐group study

    Comparison of topiroxostat and allopurinol in Japanese hyperuricemic patients with or without gout: a phase 3, multicentre, randomized, double‐blind, double‐dummy, active‐controlle... gan Tatsuo Hosoya, Yoshihiro Ogawa, Hiroya Hashimoto, Tetsuo Ohashi, Ryusuke Sakamoto

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Identification of two mutations in human xanthine dehydrogenase gene responsible for classical type I xanthinuria.

    Identification of two mutations in human xanthine dehydrogenase gene responsible for classical type I xanthinuria. gan Kimiyoshi Ichida, Yoshihiro Amaya, Naoyuki Kamatani, Tomoko Nishino, Tatsuo Hosoya, O Sakai

    Cyhoeddwyd 1997
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Urate transport via human PAH transporter hOAT1 and its gene structure

    Urate transport via human PAH transporter hOAT1 and its gene structure gan Kimiyoshi Ichida, Makoto Hosoyamada, Hiroaki Kimura, Michio Takeda, Yasunori Utsunomiya, Tatsuo Hosoya, Hitoshi Endou

    Cyhoeddwyd 2003
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Clinical and Molecular Analysis of Patients with Renal Hypouricemia in Japan-Influence of URAT1 Gene on Urinary Urate Excretion

    Clinical and Molecular Analysis of Patients with Renal Hypouricemia in Japan-Influence of URAT1 Gene on Urinary Urate Excretion gan Kimiyoshi Ichida, Makoto Hosoyamada, Ichiro Hisatome, Atsushi Enomoto, Miho Hikita, Hitoshi Endou, Tatsuo Hosoya

    Cyhoeddwyd 2004
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Low Glomerular Density with Glomerulomegaly in Obesity-Related Glomerulopathy

    Low Glomerular Density with Glomerulomegaly in Obesity-Related Glomerulopathy gan Nobuo Tsuboi, Yasunori Utsunomiya, Go Kanzaki, Kentaro Koike, Masahiro Ikegami, Tetsuya Kawamura, Tatsuo Hosoya

    Cyhoeddwyd 2012
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Positive and Negative Regulations of the Renal 25-Hydroxyvitamin D3 1α-Hydroxylase Gene by Parathyroid Hormone, Calcitonin, and 1α,25(OH)2D3 in Intact Animals*

    Positive and Negative Regulations of the Renal 25-Hydroxyvitamin D3 1α-Hydroxylase Gene by Parathyroid Hormone, Calcitonin, and 1α,25(OH)2D3 in Intact Animals* gan Akiko Murayama, Ken‐ichi Takeyama, Sachiko Kitanaka, Yasuo Kodera, Yoshindo Kawaguchi, Tatsuo Hosoya, Shigeaki Kato

    Cyhoeddwyd 1999
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Effects of topiroxostat on the serum urate levels and urinary albumin excretion in hyperuricemic stage 3 chronic kidney disease patients with or without gout

    Effects of topiroxostat on the serum urate levels and urinary albumin excretion in hyperuricemic stage 3 chronic kidney disease patients with or without gout gan Tatsuo Hosoya, Iwao Ohno, Shinsuke Nomura, Ichiro Hisatome, Shunya Uchida, Shin Fujimori, Tetsuya Yamamoto, Shigeko Hara

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Serum leptin, abdominal obesity and the metabolic syndrome in individuals with chronic spinal cord injury

    Serum leptin, abdominal obesity and the metabolic syndrome in individuals with chronic spinal cord injury gan Yukio Maruyama, Masato Mizuguchi, Tokikage Yaginuma, Masafumi Kusaka, Hiroshi Yoshida, K Yokoyama, Yasuhiro Kasahara, Tatsuo Hosoya

    Cyhoeddwyd 2008
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Uric acid-lowering and renoprotective effects of topiroxostat, a selective xanthine oxidoreductase inhibitor, in patients with diabetic nephropathy and hyperuricemia: a randomized, double-blind, placebo-controlled, parallel-group study (UPWARD study)

    Uric acid-lowering and renoprotective effects of topiroxostat, a selective xanthine oxidoreductase inhibitor, in patients with diabetic nephropathy and hyperuricemia: a randomized,... gan Takashi Wada, Tatsuo Hosoya, Daisuke Honda, Ryusuke Sakamoto, Kazutaka Narita, Tomomitsu Sasaki, Daisuke Okui, Kenjiro Kimura

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Xenobiotic Kidney Organogenesis from Human Mesenchymal Stem Cells Using a Growing Rodent Embryo

    Xenobiotic Kidney Organogenesis from Human Mesenchymal Stem Cells Using a Growing Rodent Embryo gan Takashi Yokoo, Akira Fukui, Toya Ohashi, Yoichi Miyazaki, Yasunori Utsunomiya, Tetsuya Kawamura, Tatsuo Hosoya, Masataka Okabe, Eiji Kobayashi

    Cyhoeddwyd 2006
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    The Potential of Bone Marrow-Derived Cells to Differentiate to Glomerular Mesangial Cells

    The Potential of Bone Marrow-Derived Cells to Differentiate to Glomerular Mesangial Cells gan Toshiyuki Imasawa, Yasunori Utsunomiya, Tetsuya Kawamura, Yu Zhong, Ryuji Nagasawa, Masaru Okabe, Naoki Maruyama, Tatsuo Hosoya, Tsuneya Ohno

    Cyhoeddwyd 2001
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Serum uric acid and the incidence of CKD and hypertension

    Serum uric acid and the incidence of CKD and hypertension gan Satoru Kuriyama, Yukio Maruyama, Shinichiro Nishio, Yasuhito Takahashi, Satoshi Kidoguchi, Chisa Kobayashi, Daisuke Takahashi, Naoki Sugano, Tatsuo Hosoya, Takashi Yokoo

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Oxidative stress is enhanced in correlation with renal dysfunction: Examination with the redox state of albumin

    Oxidative stress is enhanced in correlation with renal dysfunction: Examination with the redox state of albumin gan Hiroyuki Terawaki, Kazunobu Yoshimura, Toshio Hasegawa, Yukie Matsuyama, Tsuneo Negawa, Ken‐ichi Yamada, Masato Matsushima, Masaaki Nakayama, Tatsuo Hosoya, Seiichi Era

    Cyhoeddwyd 2004
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Glomerular Density in Renal Biopsy Specimens Predicts the Long-Term Prognosis of IgA Nephropathy

    Glomerular Density in Renal Biopsy Specimens Predicts the Long-Term Prognosis of IgA Nephropathy gan Nobuo Tsuboi, Tetsuya Kawamura, Kentaro Koike, Hideo Okonogi, Keita Hirano, Akihiko Hamaguchi, Yoichi Miyazaki, Makoto Ogura, Kensuke Joh, Yasunori Utsunomiya, Tatsuo Hosoya

    Cyhoeddwyd 2009
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Human mesenchymal stem cells in rodent whole-embryo culture are reprogrammed to contribute to kidney tissues

    Human mesenchymal stem cells in rodent whole-embryo culture are reprogrammed to contribute to kidney tissues gan Takashi Yokoo, Toya Ohashi, Jin Song Shen, Ken Sakurai, Yoichi Miyazaki, Yasunori Utsunomiya, Masanori Takahashi, Yoshio Terada, Yoshikatsu Eto, Tetsuya Kawamura, Noriko Osumi, Tatsuo Hosoya

    Cyhoeddwyd 2005
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Delayed In Vivo Catabolism of Intermediate-Density Lipoprotein and Low-Density Lipoprotein in Hemodialysis Patients as Potential Cause of Premature Atherosclerosis

    Delayed In Vivo Catabolism of Intermediate-Density Lipoprotein and Low-Density Lipoprotein in Hemodialysis Patients as Potential Cause of Premature Atherosclerosis gan Katsunori Ikewaki, Juergen R. Schaefer, Michael E. Frischmann, Keio Okubo, Tatsuo Hosoya, Seibu Mochizuki, Benjamin Dieplinger, Evi Trenkwalder, Horst Schweer, Florian Kronenberg, Paul-Albert Koenig, Hans Dieplinger

    Cyhoeddwyd 2005
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: